AA
GMAB icon

ABC Arbitrage’s Genmab GMAB Stock Holding History

ABC Arbitrage’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-105,871
Closed -$3.26M – 425
2025
Q4 		$3.26M Buy
+105,871
New +$3.3M 0.31% 68
2025
Q3 		– Sell
-447,055
Closed -$9.24M – 239
2025
Q2 		$9.24M Buy
+447,055
New +$9.18M 1.05% 24
2025
Q1 		– Sell
-176,898
Closed -$3.69M – 226
2024
Q4 		$3.69M Buy
+176,898
New +$3.89M 0.53% 51

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

ABC Arbitrage's GMAB Position: Q1 2026 in Review

ABC Arbitrage sold out of Genmab (GMAB) in Q1 2026, closing a stake of 105,871 shares — an estimated $3.26M sold.

ABC Arbitrage first reported a position in GMAB in Q4 2024 and held it in 3 quarters. The position peaked at $9.24M in Q2 2025. 273 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • ABC Arbitrage reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • ABC Arbitrage sold 105,871 Genmab shares in Q1 2026, an estimated $3.26M.
  • ABC Arbitrage first reported a position in Genmab in Q4 2024 and held it in 3 quarters.
  • ABC Arbitrage's Genmab position peaked at $9.24M in Q2 2025.
  • 273 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on ABC Arbitrage's 13F filing for Q1 2026, filed 4 May 2026.